Pirouette Pharma Inc.
Pirouette Pharma is a clinical-stage pharmaceutical company focused on simplifying chronic injectable care with the development of a patient-centric, hidden-needle auto-injector platform for self-administration of essential medicines at home or in high-stress settings. Leveraging engineering, automation, and regulatory expertise, the company’s mission is to improve adherence, persistence, and comfort for chronic and rescue therapies while enabling scalable manufacturing in the United States. Pirouette partners with pharmaceutical companies for the co-development and distribution of both novel and established injectables using abbreviated FDA regulatory pathways.
Industries
Nr. of Employees
small (1-50)
Pirouette Pharma Inc.
Portsmouth, New Hampshire, United States
Patents
Products
Hidden-needle auto-injector platform
Disc-shaped, push-button, automatic injection system with a completely hidden needle and controlled insertion; designed for prefilled single-use delivery of chronic and rescue injectables.
Hidden-needle auto-injector platform
Disc-shaped, push-button, automatic injection system with a completely hidden needle and controlled insertion; designed for prefilled single-use delivery of chronic and rescue injectables.
Expertise Areas
- Injectable drug delivery systems
- Human factors engineering
- Regulatory compliance for combination products
- Automation in medical device manufacturing
Key Technologies
- Automatic needle-retracting injection mechanism
- Human factors engineering for drug delivery
- Environmental ruggedization for devices
- Automated device assembly and packaging
News & Updates
Pirouette Pharma presented innovation at the New Hampshire MedTech Lightning Showcase in Nashua.
Investor community update highlighted progress in platform development, operational and manufacturing advances, and quality systems improvements.
$4.3M raised in a second community round, with 70% returning investors and additional investment from Safar Partners.
Company update included IND filing, expansion of manufacturing, and leadership team growth.
Expanded to a 10,000-sq-ft facility featuring ISO Class 8 clean room supporting platform development.
Naloxone auto-injector named Product of the Year by the New Hampshire Tech Alliance.
Pirouette Pharma presented innovation at the New Hampshire MedTech Lightning Showcase in Nashua.
Investor community update highlighted progress in platform development, operational and manufacturing advances, and quality systems improvements.
$4.3M raised in a second community round, with 70% returning investors and additional investment from Safar Partners.
Company update included IND filing, expansion of manufacturing, and leadership team growth.
Expanded to a 10,000-sq-ft facility featuring ISO Class 8 clean room supporting platform development.
Naloxone auto-injector named Product of the Year by the New Hampshire Tech Alliance.